Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease

By  

Brain And Behavior, Vol. 8, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease

By Taylor Julie   Hulihan Mary   Kachergus Jennifer   Melrose Heather   Lincoln Sarah   Hinkle Kelly   Stone Jeremy   Ross Owen   Hauser Robert   Aasly Jan   Gasser Thomas   Payami Haydeh   Wszolek Zbigniew   Farrer Matthew  

Neurogenetics, Vol. 8, Iss. 2, 2007-04 ,pp. : 95-102

Springer Publishing Company

Access to resources Recommend Favorite

A study of six point mutation analysis of LRRK2 gene in Chinese mainland patients with Parkinson's disease

By Hu Z.  

Neurological Sciences, Vol. 32, Iss. 4, 2011-08 ,pp. : 741-742

Springer Publishing Company

Access to resources Recommend Favorite

LRRK2 mutations, regulation and 14–3–3 protein interaction: implications for Parkinson’s disease

By Dzamko Nicolas   Alessi Dario R  

Future Neurology, Vol. 6, Iss. 1, 2011-01 ,pp. : 5-8

Future Medicine

Access to resources Recommend Favorite

RNA interference of LRRK2-microarray expression analysis of a Parkinson's disease key player

By Häbig K.  

Neurogenetics, Vol. 9, Iss. 2, 2008-05 ,pp. : 83-94

Springer Publishing Company

Access to resources Recommend Favorite